Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Confronting the complexity of EGFR/HER targeted therapies in breast, colorectal and lung cancers

A panel of European experts discusses current and emerging issues in breast, lung and colorectal cancers, highlighting possible shared approaches in a context of personalised cancer medicine.. They also critically discuss why we see success in one disease type but failures in others although they share the same underlying pathways.
From the first ESMO Signalling pathways symposium

Video produced by the European Society for Medical Oncology (ESMO)

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.